App-Quantinova.ai

Management of Anticoagulant Therapy around Delivery: Results from the Ongoing Highlow Study

I. Bistervels - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Current ISTH Registries on Women´s Health Issues in Thrombosis and Haemostasis: Powerful Tools for Improved Data Collection and Outcome Measurement

M. Othman - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

A Qualitative Analysis on Patient Understanding with Anticoagulation Use & Indication and the Effect of Nurse Practitioner Led Patient Education

L. Sardo - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Management of Isolated Distal Deep Vein Thrombosis in Pediatrics: A Survey of CPTHN and ISTH SSC Members

R. Goldsmith - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Deep vein thrombosis

N/A

Scapular Site Injection of Low Molecular Weight Heparin in Neonates: Study Update

R. Goldsmith - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Heparin

Evaluation of the Clinical Utility of Biomarkers for Stroke Risk Scoring in Non‐anticoagulated Patients with Atrial Fibrillation – An ACTIVE‐A and AVERROES Sub‐analysis

M. Lauw - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

apixaban

Effect of DOAC Type and DOAC Dose, and Residual DOAC Level on Risk for Perioperative Major Bleeding and Arterial Thromboembolism

J. Douketis - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

rivaroxaban

Deletion of CD248, a Novel Cofactor for Tissue Factor (TF), Confers Protection against Thrombosis in a Mouse Model

P.R. Kapopara - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

folitixorin calcium

A Safe and Potent Antithrombotic Agent: Salvianolic Acid B Inhibits Platelet Aggregation and Blood Coagulation

M.A.D. Neves - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Intestinal Microbiome Affects Thrombin Generation in Human Subjects Through Effects on Coagulation Related Plasma Protein Levels

Y. Mohammed - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Metabolic syndrome

Evithrom

Patient Reported Outcome Data on Switch from Standard to Extended Half Life in Irish Adults with Haemophilia

B. O'Mahony - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Differential Production of Cytokines in Response to FVIII in Hemophilia Patients Undergoing ITI: A Preliminary Analysis of a Multi‐center Longitudinal Study

D. Matino - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

Isolation of Silica‐free DNA and Studies of its Effects on Organ Damage in Mice

S.K. Medeiros - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Evithrom

Different Protein Spectrum in Patients with Venous Thrombosis after Lower Leg Plaster Cast Application or Knee Arthroscopy than in Controls

Y. Mohammed - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Generating Plasma Protein Signatures for Murine Venous Thrombosis and Slc44a2 Deficiency Using a Multiplex Targeted Proteomics Approach

J. Tilburg - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Protein C

CLOTSref: A Mobile Application for Standardized Reference Ranges in Developmental Haemostasis

P.T. Tieu - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Hemostatic Solution

Activated Thrombin Activable Fibrinolysis Inhibitor (TAFIa) Regulates Plasmin Generation on Thrombin‐activated Platelets

P.Y. Kim - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Fibrinogen (IV)

Common and Rare Genetic Determinants of von Willebrand Factor Clearance and Factor VIII‐binding Modify Factor VIII Pharmacokinetics in a Pediatric Hemophilia A Population

L.L. Swystun - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

rFVIII

Mixed Phenotype von Willebrand Disease Caused by a Novel Cysteine Variant that Results in Both Qualitative and Quantitative von Willebrand Factor Defects

O. Rawley - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

Hemostatic Solution

Oral Nanoparticles with FVIII and IL‐10 DNA: Effect on the Immune Response to FVIII in Hemophilia A Mice

Z. Yerkesh - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

chitosan

Filters

28841 Abstracts